Janssen Biotech, Inc.
10 drugs in NADAC|0 Generic,10 Brand
Janssen Biotech, Inc. lists 10 NDCs in the CMS NADAC file (0 generic, 10 brand), at an average NADAC of $13112.60 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
10
0G / 10B
Avg Price / Unit
$13112.6007
$87.63 – $29841.65
Avg 7d Change
-0.18%
Across 1 drugs with changes
7d Activity
of 10 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Frequently Asked Questions
How many drugs does Janssen Biotech, Inc. make?
Janssen Biotech, Inc. lists 10 NDCs in the CMS NADAC file — 0 generic and 10 brand products.
What is the average price of Janssen Biotech, Inc. drugs?
The average NADAC across Janssen Biotech, Inc.'s portfolio is $13112.6007 per unit, ranging from $87.6254 to $29841.6480.
What types of drugs does Janssen Biotech, Inc. make?
Janssen Biotech, Inc. makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Interleukin-23 Antagonist (5), Tumor Necrosis Factor Blocker (4), Interleukin-12 Antagonist (2), Cytochrome P450 17A1 Inhibitor (1).
Has Janssen Biotech, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Janssen Biotech, Inc. in the openFDA feed.
How has Janssen Biotech, Inc.'s pricing changed recently?
Over the past 7 days, 0 Janssen Biotech, Inc. products rose and 1 fell, with a portfolio-wide average change of -0.2%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
STELARA 45 MG/0.5 ML SYRINGE ustekinumab | $29841.6480 per ML | — |
STELARA 90 MG/ML SYRINGE ustekinumab | $29797.8880 per ML | — |
TREMFYA 100 MG/ML SYRINGE Guselkumab | $14779.6320 per ML | — |
TREMFYA 100 MG/ML ONE-PRESS Guselkumab | $14740.0180 per ML | — |
SIMPONI 50 MG/0.5 ML SYRINGE golimumab | $12977.2440 per ML | — |
SIMPONI 50 MG/0.5 ML PEN INJEC golimumab | $12970.1029 per ML | -0.18% |
SIMPONI 100 MG/ML PEN INJECTOR golimumab | $7446.2126 per ML | — |
TREMFYA 200 MG/2 ML PEN guselkumab | $7349.6703 per ML | — |
REMICADE 100 MG VIAL INFLIXIMAB | $1135.9660 per EA | — |
ZYTIGA 250 MG TABLET abiraterone acetate | $87.6254 per EA | — |